CellsBin® Closes Series A Financing Led by 108 BioCapital to Advance Its Rare-Cell Intelligence™ Platform

Investment will accelerate commercialization, strategic partnerships, product development and expansion of CellsBin's clinical and technical capabilities BRANFORD, Conn., Sept. 22, 2026 /PRNewswire/ -- CellsBin, a biotechnology company pioneering Rare-Cell Biology™, today announced the...